vs

Side-by-side financial comparison of Aramark (ARMK) and IQVIA (IQV). Click either name above to swap in a different company.

Aramark is the larger business by last-quarter revenue ($4.8B vs $4.4B, roughly 1.1× IQVIA). IQVIA runs the higher net margin — 11.8% vs 2.0%, a 9.8% gap on every dollar of revenue. On growth, IQVIA posted the faster year-over-year revenue change (10.3% vs 6.1%). IQVIA produced more free cash flow last quarter ($561.0M vs $-904.4M). Over the past eight quarters, IQVIA's revenue compounded faster (8.1% CAGR vs 7.3%).

Aramark is an American food service and facilities services provider to clients in areas including education, prisons, healthcare, business, and leisure. It operates in North America and an additional 14 countries, including the United Kingdom, Germany, Chile, Ireland, and Spain.

IQVIA Holdings, Inc., headquartered in Durham, North Carolina, is an American company focused on health information technology and clinical research.

ARMK vs IQV — Head-to-Head

Bigger by revenue
ARMK
ARMK
1.1× larger
ARMK
$4.8B
$4.4B
IQV
Growing faster (revenue YoY)
IQV
IQV
+4.1% gap
IQV
10.3%
6.1%
ARMK
Higher net margin
IQV
IQV
9.8% more per $
IQV
11.8%
2.0%
ARMK
More free cash flow
IQV
IQV
$1.5B more FCF
IQV
$561.0M
$-904.4M
ARMK
Faster 2-yr revenue CAGR
IQV
IQV
Annualised
IQV
8.1%
7.3%
ARMK

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ARMK
ARMK
IQV
IQV
Revenue
$4.8B
$4.4B
Net Profit
$96.2M
$514.0M
Gross Margin
Operating Margin
4.5%
14.4%
Net Margin
2.0%
11.8%
Revenue YoY
6.1%
10.3%
Net Profit YoY
-9.0%
17.6%
EPS (diluted)
$0.36
$2.97

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARMK
ARMK
IQV
IQV
Q1 26
$4.8B
Q4 25
$5.0B
$4.4B
Q3 25
$4.1B
Q2 25
$4.6B
$4.0B
Q1 25
$4.3B
$3.8B
Q4 24
$4.6B
$4.0B
Q3 24
$4.4B
$3.9B
Q2 24
$4.4B
$3.8B
Net Profit
ARMK
ARMK
IQV
IQV
Q1 26
$96.2M
Q4 25
$87.1M
$514.0M
Q3 25
$331.0M
Q2 25
$71.8M
$266.0M
Q1 25
$61.9M
$249.0M
Q4 24
$105.6M
$437.0M
Q3 24
$122.4M
$285.0M
Q2 24
$58.1M
$363.0M
Gross Margin
ARMK
ARMK
IQV
IQV
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
23.5%
Q2 24
22.6%
Operating Margin
ARMK
ARMK
IQV
IQV
Q1 26
4.5%
Q4 25
4.3%
14.4%
Q3 25
13.5%
Q2 25
3.9%
12.6%
Q1 25
4.1%
13.0%
Q4 24
4.8%
15.8%
Q3 24
5.0%
14.1%
Q2 24
3.7%
13.6%
Net Margin
ARMK
ARMK
IQV
IQV
Q1 26
2.0%
Q4 25
1.7%
11.8%
Q3 25
8.1%
Q2 25
1.6%
6.6%
Q1 25
1.4%
6.5%
Q4 24
2.3%
11.0%
Q3 24
2.8%
7.3%
Q2 24
1.3%
9.5%
EPS (diluted)
ARMK
ARMK
IQV
IQV
Q1 26
$0.36
Q4 25
$0.33
$2.97
Q3 25
$1.93
Q2 25
$0.27
$1.54
Q1 25
$0.23
$1.40
Q4 24
$0.39
$2.41
Q3 24
$0.46
$1.55
Q2 24
$0.22
$1.97

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARMK
ARMK
IQV
IQV
Cash + ST InvestmentsLiquidity on hand
$439.6M
$2.1B
Total DebtLower is stronger
$6.2B
Stockholders' EquityBook value
$3.2B
$6.5B
Total Assets
$13.5B
$29.9B
Debt / EquityLower = less leverage
1.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARMK
ARMK
IQV
IQV
Q1 26
$439.6M
Q4 25
$639.1M
$2.1B
Q3 25
$2.0B
Q2 25
$501.5M
$2.2B
Q1 25
$920.5M
$1.9B
Q4 24
$484.1M
$1.8B
Q3 24
$672.5M
$1.7B
Q2 24
$436.1M
$1.7B
Total Debt
ARMK
ARMK
IQV
IQV
Q1 26
$6.2B
Q4 25
$5.4B
Q3 25
Q2 25
$6.3B
Q1 25
$6.1B
Q4 24
$5.0B
Q3 24
$4.3B
Q2 24
$5.0B
Stockholders' Equity
ARMK
ARMK
IQV
IQV
Q1 26
$3.2B
Q4 25
$3.1B
$6.5B
Q3 25
$6.2B
Q2 25
$3.1B
$5.8B
Q1 25
$3.0B
$6.0B
Q4 24
$3.1B
$6.1B
Q3 24
$3.0B
$7.0B
Q2 24
$2.9B
$6.7B
Total Assets
ARMK
ARMK
IQV
IQV
Q1 26
$13.5B
Q4 25
$13.3B
$29.9B
Q3 25
$28.7B
Q2 25
$13.3B
$28.6B
Q1 25
$13.5B
$27.3B
Q4 24
$12.7B
$26.9B
Q3 24
$12.7B
$27.2B
Q2 24
$12.5B
$26.4B
Debt / Equity
ARMK
ARMK
IQV
IQV
Q1 26
1.94×
Q4 25
1.71×
Q3 25
Q2 25
2.03×
Q1 25
2.02×
Q4 24
1.61×
Q3 24
1.42×
Q2 24
1.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARMK
ARMK
IQV
IQV
Operating Cash FlowLast quarter
$-782.2M
$735.0M
Free Cash FlowOCF − Capex
$-904.4M
$561.0M
FCF MarginFCF / Revenue
-18.7%
12.9%
Capex IntensityCapex / Revenue
2.5%
4.0%
Cash ConversionOCF / Net Profit
-8.13×
1.43×
TTM Free Cash FlowTrailing 4 quarters
$2.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARMK
ARMK
IQV
IQV
Q1 26
$-782.2M
Q4 25
$735.0M
Q3 25
$908.0M
Q2 25
$76.7M
$443.0M
Q1 25
$255.9M
$568.0M
Q4 24
$-587.2M
$885.0M
Q3 24
$1.0B
$721.0M
Q2 24
$140.7M
$588.0M
Free Cash Flow
ARMK
ARMK
IQV
IQV
Q1 26
$-904.4M
Q4 25
$561.0M
Q3 25
$772.0M
Q2 25
$-34.7M
$292.0M
Q1 25
$140.1M
$426.0M
Q4 24
$-707.0M
$721.0M
Q3 24
$882.3M
$571.0M
Q2 24
$55.6M
$445.0M
FCF Margin
ARMK
ARMK
IQV
IQV
Q1 26
-18.7%
Q4 25
12.9%
Q3 25
18.8%
Q2 25
-0.8%
7.3%
Q1 25
3.3%
11.1%
Q4 24
-15.5%
18.2%
Q3 24
20.0%
14.7%
Q2 24
1.3%
11.7%
Capex Intensity
ARMK
ARMK
IQV
IQV
Q1 26
2.5%
Q4 25
2.8%
4.0%
Q3 25
3.3%
Q2 25
2.4%
3.8%
Q1 25
2.7%
3.7%
Q4 24
2.6%
4.1%
Q3 24
3.2%
3.9%
Q2 24
1.9%
3.7%
Cash Conversion
ARMK
ARMK
IQV
IQV
Q1 26
-8.13×
Q4 25
1.43×
Q3 25
2.74×
Q2 25
1.07×
1.67×
Q1 25
4.14×
2.28×
Q4 24
-5.56×
2.03×
Q3 24
8.35×
2.53×
Q2 24
2.42×
1.62×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARMK
ARMK

Education$1.1B22%
Sports Leisure Corrections$961.2M20%
Food And Support Services International$847.8M18%
Other$621.6M13%
Businessand Industry$510.6M11%
Health Care$421.3M9%
Facility Services$382.9M8%

IQV
IQV

Segment breakdown not available.

Related Comparisons